Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The condition may be benign (Raynaud disease) or associated with an autoimmune disease (secondary Raynaud phenomenon)
Imura T et al
Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer
J Cancer Res.Clin Oncol
A 2020 review on the safety of BPC-157 in preclinical (animal) studies states that the peptide did not show any test-related effects in the single-dose toxicity study and that it was well tolerated in repeat-dose evaluations.16 Other animal studies and reviews mention that BPC-157 has no reported toxicity or that it was without a lethal dose in toxicology studies.14 17 Even the authors of a small human study on BPC-157 for interstitial cystitis note that no one dropped out of the study, and no adverse events were reported.18 We want to highlight that most of the relevant studies have been conducted on animals, and more human research is needed
If for any reason you're not completely satisfied, take advantage of our hassle-free money-back guarantee
